The fully automated synthetic biology platform for Accelerating discovery
Optimize your discovery workflows in antibody therapeutics, vaccines, precision medicine and more by building biology overnight on the BioXp™ platform.
Revolutionizing synthetic biology on your benchtop
Telesis Bio aims to inspire and empower scientific breakthroughs in Life Sciences and Translational Research. Designed to revolutionize synthetic biology, our award-winning BioXp™ System accelerates the design-build-test process of the product development cycle by building biology – overnight and at the push of a button.
Expand and accelerate discovery by synthesizing candidate sequences in days not weeks or months.
Leverage the reliability and ease of automation to optimize resource utilization in discovery.
Build biology in your own lab, and on your own schedule
The automated BioXp system produces a variety of synthetic biology products for discovery. BioXp users include premier academic research institutions, emerging start-ups, and nearly all of the Top 25 Biopharma companies. Users span various areas of discovery; from novel infectious disease vaccines, to precision immunotherapy for cancer and antibody therapeutics, to creation of engineered meat substitutes and sustainable cellular agricultural products.
The BioXp™ 3250 system
The award-winning BioXp 3250 system accelerates the design-build-test process of the discovery cycles by enabling rapid automated synthesis of genes, clones, variant libraries and mRNA.
The BioXp™ 9600 system
The next-generation BioXp system, designed to accelerate high-throughput screening and discovery workflows. The BioXp 9600 enables seamless synthesis of up to 96 candidate genes and clones overnight.
Harness the power of automated synthetic biology
The BioXp™ platform enables hands-free and rapid, automated synthesis of biological sequences at the push of a button. The System is designed for ease-of-use and does not require any special skill set nor knowledge to operate.
Several scientific innovations enable the system’s capabilities. The state-of-the-art automation technology of the BioXp platform includes innovative motion control, fluid handling, and on-deck thermocycling capabilities. A proprietary version of the trusted Gibson Assembly® method that enables seamless assembly paired with our two-step error correction process that supports mismatch identification and repair results in high-fidelity synthesis of DNA. Combining this synthesis chemistry with our state-of-the-art automation platform further streamlines the workflow enabling the high-throughput, overnight synthesis of DNA and mRNA.